Summary of Significant Accounting Policies - Antidilutive securities and EPS (Details) - shares |
12 Months Ended | ||
|---|---|---|---|
Jan. 31, 2026 |
Feb. 01, 2025 |
Feb. 03, 2024 |
|
| Reconciliation of average number of common shares outstanding used to calculate basic and diluted earnings per share | |||
| Weighted average number of common shares outstanding (basic) | 8,057,405 | 8,314,825 | 8,221,450 |
| Incremental shares from assumed vesting of nonvested restricted stock | 242,685 | ||
| Weighted average number of common shares and common stock equivalents outstanding (diluted) | 8,300,090 | 8,314,825 | 8,221,450 |
| Time-Based Restricted Stock | |||
| Reconciliation of average number of common shares outstanding used to calculate basic and diluted earnings per share | |||
| Securities excluded from calculation of diluted earnings per share (in shares) | 0 | 248,000 | 273,000 |